Compare MET & CL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MET | CL |
|---|---|---|
| Founded | 1863 | 1806 |
| Country | United States | United States |
| Employees | 46000 | N/A |
| Industry | Life Insurance | Package Goods/Cosmetics |
| Sector | Finance | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.0B | 73.2B |
| IPO Year | N/A | 2008 |
| Metric | MET | CL |
|---|---|---|
| Price | $99.84 | $92.40 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 17 |
| Target Price | $93.93 | ★ $94.19 |
| AVG Volume (30 Days) | 3.8M | ★ 4.5M |
| Earning Date | 05-06-2026 | 05-01-2026 |
| Dividend Yield | ★ 2.88% | 2.51% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.67 |
| Revenue | N/A | ★ $15,454,000,000.00 |
| Revenue This Year | $4.40 | $7.49 |
| Revenue Next Year | $4.51 | $3.28 |
| P/E Ratio | ★ $16.82 | $55.86 |
| Revenue Growth | N/A | ★ 1.70 |
| 52 Week Low | $67.33 | $74.55 |
| 52 Week High | $97.80 | $99.33 |
| Indicator | MET | CL |
|---|---|---|
| Relative Strength Index (RSI) | 72.05 | 56.45 |
| Support Level | $74.63 | $93.27 |
| Resistance Level | N/A | $96.38 |
| Average True Range (ATR) | 1.67 | 2.13 |
| MACD | -0.00 | 0.09 |
| Stochastic Oscillator | 97.95 | 75.68 |
MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: Group Benefits, Retirement and Income Solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Holdings (products in run-off). Group Benefits and RIS are US-based, contributing to around 48% of the firm's 2024 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 13% of 2024 earnings. The EMEA and MetLife Holdings segments contributed around 4% and 10% of 2024 earnings, respectively.
Since its founding in 1806, Colgate-Palmolive has grown into a leading player in the household and personal care industry. In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and home care products sold in over 200 countries. International sales account for about 70% of its total business, including nearly half from emerging regions. It also owns specialty pet food maker Hill's (almost one-fourth of sales), which sells the majority of its products through veterinarians and specialty pet retailers.